Latest Share Chat

REMOVE ADS

BVX.L Share News (BVX)

BVX.L Information

There is currently no data for BVX

REMOVE ADS

BVX.L News

Bivictrix granted FDA orphan drug status for rare cancer treatment

(Alliance News) - Bivictrix Therapeutics PLC on Wednesday said its BVX001 drug has been granted special status by the US Food and Drug Administration....

IN BRIEF: Bivictrix selects final sequences for lead tumour programme

Bivictrix Therapeutics PLC - Macclesfield, England-based biotechnology company focused on cancer therapies - Says final sequences have been selected f...

TRADING UPDATES: BiVictriX patent boost; 4Global deal extended

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

BiVictriX gets patent for its lead asset in Japan

(Sharecast News) - BiVictriX Therapeutics has received a patent grant from the Japanese Patent Office (JPO) for its lead asset BVX001, it announced on...

BiVictriX posts promising preclinical data on leukaemia candidate

(Sharecast News) - Biotechnology company BiVictriX Therapeutics updated the market on the pre-clinical evaluation of BVX001 on Thursday - its first-in...

Bivictrix says BVX001 increases survival rates by more than double

(Alliance News) - Bivictrix Therapeutics PLC on Thursday said its Bi-Cygni antibody-drug conjugate, BVX001, showed survival rates more than doubled in...

Bivictrix hires new CFO as Alex Hughes steps down after seven months

(Alliance News) - Bivictrix Therapeutics PLC on Tuesday said it has appointed Adrian Howd as chief financial officer and chief business officer as CFO...

BiVictriX appoints Adrian Howd as its new finance chief

(Sharecast News) - Biotechnology developer BiVictriX Therapeutics announced the appointment of Dr Adrian Howd as its chief financial officer (CFO) and...